Hsp72 (HSPA1A) Prevents Human Islet Amyloid Polypeptide Aggregation and Toxicity: A New Approach for Type 2 Diabetes Treatment
dc.creator | Rosas, Paola C. | |
dc.creator | Nagaraja, Ganachari M. | |
dc.creator | Kaur, Punit | |
dc.creator | Panossian, Alexander | |
dc.creator | Wickman, Georg | |
dc.creator | Garcia, L. Rene | |
dc.creator | Al-Khamis, Fahd A. | |
dc.creator | Asea, Alexzander A. A. | |
dc.creator | Tharakan, Binu | |
dc.date.accessioned | 2019-10-09T20:59:40Z | |
dc.date.available | 2019-10-09T20:59:40Z | |
dc.date.issued | 2016 | |
dc.identifier.issn | 1932-6203 | |
dc.identifier.uri | https://hdl.handle.net/1969.1/182122 | |
dc.format.extent | 0 | en |
dc.publisher | PloS One | |
dc.relation.ispartof | 1foldr Import 2019-10-08 Batch 8 | en |
dc.relation.uri | 10.1371/journal.pone.0149409 | en |
dc.title | Hsp72 (HSPA1A) Prevents Human Islet Amyloid Polypeptide Aggregation and Toxicity: A New Approach for Type 2 Diabetes Treatment | en |